Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) – a study protocol

BACKGROUND: Patients with type 2 diabetes (T2D) are at increased risk for developing cancer. As approximately 8% of the world’s population is living with T2D, even a slight increase in cancer risk could result in an enormous impact on the number of persons developing cancer. In addition, several glu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Schrijnders, Dennis, de Bock, Geertruida H., Houweling, Sebastiaan T., van Hateren, Kornelis J. J., Groenier, Klaas H., Johnson, Jeffrey A., Bilo, Henk J. G., Kleefstra, Nanne, Landman, Gijs W. D.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5482962/
https://ncbi.nlm.nih.gov/pubmed/28645260
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3433-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados